About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | NM404 as an Imaging Agent in Patients With NSCLC

NM404 as an Imaging Agent in Patients With NSCLC

NCT00582283·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Wisconsin, Madison

With

National Cancer Institute (NCI)
Cellectar Biosciences, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Histologically or cytologically documented NSCLC with measurable of disease
Disease is evaluable by CT scan
At least 18 years old. Women cannot be pregnant or breastfeeding
Karnofsky score \>/= to 60
Adequate renal/hepatic function
Adequate blood cell count levels

You may not be if

Concomitant infection
Other active cancers

The record

StatusCompleted

PhasePhase 1

Taking part21

StartedJan 2004

UpdatedMay 22, 2019

Conditions

Non Small Cell Lung Cancer

Where1

University of Wisconsin Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States